P388白血病对各类抗肿瘤药物体内耐药性发展的比较研究。 - Suppr

Suppr

超能文献

Comparative study of in vivo development of resistance to various classes of antitumor agents in P388 leukemia.

作者信息

Inaba M, Fujikura R, Sakurai Y

出版信息

Gan. 1979 Oct;70(5):607-13.

PMID:520752

Abstract

摘要

相似文献

Comparative study of in vivo development of resistance to various classes of antitumor agents in P388 leukemia.P388白血病对各类抗肿瘤药物体内耐药性发展的比较研究。

Gan. 1979 Oct;70(5):607-13.

[The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].[对阿霉素诱导耐药的白血病P388细胞的细胞生长抑制剂交叉耐药性]

Biull Eksp Biol Med. 1993 Sep;116(9):309-11.

[The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].[氟哌啶醇对白血病P-388细胞中阿霉素蓄积的影响以及对氟哌啶醇与阿霉素联合用药的诱导抗性]

Biull Eksp Biol Med. 1990 Mar;109(3):290-2.

Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.体内P388白血病模型在天然产物抗肿瘤活性评估中的稳定性。

Cancer Treat Rep. 1985 Jun;69(6):683-5.

Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388.抗癌药物与叶酸联合用于治疗小鼠白血病P388

Chemotherapy. 1984;30(2):119-24. doi: 10.1159/000238257.

Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.对4'-(9-吖啶基氨基)-甲磺酰间茴香胺耐药的P388白血病亚系的发育及交叉耐药特性

Eur J Cancer Clin Oncol. 1982 May;18(5):479-87. doi: 10.1016/0277-5379(82)90117-1.

Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.对阿霉素敏感和耐药的P388小鼠白血病细胞，侧支敏感抗代谢物的体外差异效应

Neoplasma. 1989;36(6):673-83.

[Search for biochemical criteria of sensitivity and resistance of tumor cells to antimetabolites].

Vestn Akad Med Nauk SSSR. 1978(5):58-64.

Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.

Cancer Treat Rep. 1976 Jan;60(1):23-7.

Cause of variability in activity of samples of CCNU against P388 leukemia in vivo.CCNU样本体内抗P388白血病活性变异性的原因。

Cancer Treat Rep. 1980 Aug-Sep;64(8-9):987-91.

引用本文的文献

Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.长春氟宁（20'，20'-二氟-3'，4'-二氢长春瑞滨），一种新型长春花生物碱，在体内和体外均参与P-糖蛋白（Pgp）介导的多药耐药。

Invest New Drugs. 1998;16(1):3-17. doi: 10.1023/a:1006022811895.

Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.新型多拉司他汀10衍生物TZT-1027的抗肿瘤活性

Jpn J Cancer Res. 1997 Mar;88(3):316-27. doi: 10.1111/j.1349-7006.1997.tb00383.x.

Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C.对丝裂霉素C敏感或耐药的小鼠P388白血病细胞对丝裂霉素C和KW-2149摄取情况的比较。

Cancer Chemother Pharmacol. 1993;32(1):20-4. doi: 10.1007/BF00685871.

Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.丝裂霉素衍生物7-N-[2-[[2-(γ-L-谷氨酰胺基)乙基]二硫代]乙基]丝裂霉素C（KW-2149）对小鼠和人类肿瘤以及一种丝裂霉素C耐药肿瘤的体内外抗肿瘤活性。

Cancer Chemother Pharmacol. 1990;27(2):89-93. doi: 10.1007/BF00689089.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验